Mar 13, 2019 / 01:00PM GMT
Unidentified Analyst -
(technical difficulty) from Barclays and for the next session of the day, we have John Higgins, CEO from Ligand Pharmaceuticals. John, over to you.
John L. Higgins - Ligand Pharmaceuticals Incorporated - CEO & Executive Director
Thank you, [Balaji]. I appreciate the introduction, and it's a pleasure to be here. Bear with my -- I have a slight winter cold. Soon to be springtime though, so bring on the sun. It's nice to be here in Miami. We arrived last evening. We were in New York City yesterday. We had our Analyst Day. Once a year, we host Analyst Day and these slides you'll see today are representing a lot of new content from that program in New York. It was a well-attended event. We're happy to be here.
Ligand, I recognize a few faces, faces we've known from the past, a few new faces, perhaps. I'm going to be talking about the business, giving forward-looking statements, describing our outlook on the business, risks the company face are represented in our SEC filed documents. We encourage you to review those documents for a full
Ligand Pharmaceuticals Inc at Barclays Global Healthcare Conference Transcript
Feb 07, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers